CDDF & EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development
5 October - 6 October
Brussels, Belgium (hybrid)
EORTC and the Cancer Drug Development Forum (CDDF) will jointly organise a two‑day multi‑stakeholder workshop focused on Health Technology Assessment (HTA) in cancer drug development. The workshop will address key challenges and opportunities related to evidence generation, assessment methodologies, and decision‑making processes across the cancer care continuum.
The event will convene experts from academia, regulatory bodies, HTA agencies, patient organisations, and other stakeholders involved in oncology research and policy.
Event information
Event page: https://cddf.org/events/upcoming-events/cddf-workshop-october-2026/
Registration: https://cddf.org/events/upcoming-events/cddf-workshop-october-2026/registration/
Registration fees
Registration is free of charge for the following participant categories:
- Academics
- Representatives from foundations, non‑profit organisations, or charities
- Regulators (national regulatory agencies, HTA bodies, EMA, FDA)
- Students and nurses
- Patient advocates
Dates: 5 – 6 October 2026
Location: hybrid, Brussels (BE)
Next events
Designing clinical trials for older adults with lung cancer
16 November @ 18:00
38th EORTC-NCI-AACR Symposium
18 November - 20 November
Barcelona, Spain
European Cancer Summit 2026
18 November - 19 November
Brussels, Belgium
EORTC Gynecological Cancer Group Autumn Meeting 2026
19 November - 20 November
Leiden, Netherlands
EORTC Leukemia Autumn Group Meeting 2026
14 December
New Orleans, USA
